INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

VRTXVERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score20
Connections17with evidence

VRTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
David J. TaylorRSelf
VRTXVERTEX PHARMACEUTICALS INC / MA
Sale
SELL$1,001 – $15KAug 26, 2026Sep 5, 2026
traded Aug 26, 2026
+10dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)FEC Form 1 connected organization: VERTEX PHARMACEUTICALS INCORPORATED (curated map) · Nov 4, 2026
  • ← Disclosed trade inevidence
    David J. TaylorSale disclosed 2026-09-05 · Sep 5, 2026
  • ← Lobbied forevidence
    CGCN GROUP, LLCLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
17
AK
Ambrose KristenSVP & Chief Accounting Officer
VRTXVERTEX PHARMACEUTICALS INC / MA
Grant or award
A
—
2,950 sh
Jan 22, 2026
Jan 26, 2026
traded Jan 22, 2026
+4d
SEC FORM 4

Evidence

13
AK
Ambrose KristenSVP & Chief Accounting Officer
VRTXVERTEX PHARMACEUTICALS INC / MA
Grant or award
A—
1,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    ALB SOLUTIONSLDA Q1 2026 first quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    HOLLAND & KNIGHT LLPLDA Q2 2026 second quarter · Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q2 2026 second quarter · Health issues, Defense · Aug 26, 2026
  • ← Lobbied forevidence
    EMPIRE CONSULTING GROUPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    STANTON PARK GROUPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    MCLARTY INBOUND LLCLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q2 2026 second quarter · Budget/appropriations, Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    MARSHALL & POPP, LLCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    SALT POINT STRATEGIESLDA 1T 2026 first quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    ALSTON & BIRD LLPLDA RR 2026 first quarter · Budget/appropriations, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    CROSSROADS STRATEGIES, LLCLDA Q2 2026 second quarter · Health issues, MED, Medicare/Medicaid, Trade · Aug 26, 2026
  • ← Insider ofevidence
    Ambrose KristenSVP & Chief Accounting Officer · Jan 26, 2026

    • Lobbying

    $2.34M reported · de-duplicated
    2026 Q2 $1.20M in-house2026 Q1 $1.14M in-house
    • ALSTON & BIRD LLP$50K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, Health issues
    • EMPIRE CONSULTING GROUP$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • ALB SOLUTIONS—2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • TIBER CREEK GROUP$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Defense
    • ALB SOLUTIONS$50K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • STANTON PARK GROUP$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • MCLARTY INBOUND LLC—2026 Q2 · posted Aug 26, 2026 ·
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, Health issues, Medicare/Medicaid
    • CROSSROADS STRATEGIES, LLC$30K2026 Q1 · posted Aug 26, 2026 · MED, Health issues, Medicare/Medicaid
    • CGCN GROUP, LLC$80K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • MCLARTY INBOUND LLC—2026 Q1 · posted Aug 26, 2026 ·
    • CGCN GROUP, LLC$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Mariannette Miller-MeeksR$10KVERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
    • Mark R. WarnerD$10KVERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
    • Nanette Diaz BarragánD$9,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
    • Diana DeGetteD$7,500VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
    • Katherine M. ClarkD$7,500
    VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Scott H. PetersD$7,500VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • John CornynR$7,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Patty MurrayD$6,500VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Margaret Wood HassanD$6,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Jake AuchinclossD$6,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Ashley MoodyR$6,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)
  • Brett GuthrieR$5,000VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC)